Goldman Sachs Group Inc Haemonetics Corp Call Options Transaction History
Goldman Sachs Group Inc
- $580 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding HAE
# of Institutions
337Shares Held
55.7MCall Options Held
383KPut Options Held
45.1K-
Capital Research Global Investors Los Angeles, CA6.92MShares$492 Million0.13% of portfolio
-
Black Rock Inc. New York, NY5.96MShares$424 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.14MShares$366 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA3.84MShares$273 Million0.06% of portfolio
-
Neuberger Berman Group LLC New York, NY3.83MShares$273 Million0.27% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.65B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...